HEALTH PROFESSIONAL · SOURCE READING
Treatment of Newly Diagnosed Childhood Craniopharyngioma
Source: Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: November 26, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
There is no consensus on the optimal treatment for patients with newly diagnosed craniopharyngioma, in part because of the lack of prospective randomized trials that compare the different treatment options. Treatment is individualized on the basis of the following factors:
Tumor size.
Tumor location.
Extension of the tumor.
Potential short-term and long-term toxicity, partially related to baseline neuroendocrine and vision deficits (i.e., more conservative surgical approaches may be prioritized in patients who do not have existing neuroendocrine or visual deficits to mitigate the risk of surgical morbidity).[1]
Source links and citations
Established treatment options for newly diagnosed childhood craniopharyngioma include the following:
Complete resection with or without radiation therapy.
Source links and citations
Subtotal resection with radiation therapy.
Source links and citations
Primary cyst drainage with or without radiation therapy.
Source links and citations
Intracystic therapy.
Source links and citations
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice
Triangle